Inactivation of Peroxiredoxin I by Phosphorylation Allows Localized H2O2 Accumulation for Cell Signaling

Cell

Volumn 140, Issue 4, 2010, Pages 517-528

  Woo, Hyun Ae ^a   Yim, Sun Hee ^a   Shin, Dong Hae ^a   Kang, Dongmin ^a   Yu, Dae Yeul ^b   Rhee, Sue Goo ^a  

^a Ewha Womans University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

PROTEINS; SIGNALING

Indexed keywords

HYDROGEN PEROXIDE; PEROXIREDOXIN 1; PEROXIREDOXIN 2; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CELL STIMULATION; CONTROLLED STUDY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WOUND HEALING;

MUS;

EID: 76749102420     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2010.01.009     Document Type: Article

References (43)

1. Bae Y.S., Kang S.W., Seo M.S., Baines I.C., Tekle E., Chock P.B., and Rhee S.G. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J. Biol. Chem. 272 (1997) 217-221
2. Bae S.H., Woo H.A., Sung S.H., Lee H.E., Lee S.K., Kil I.S., and Rhee S.G. Induction of sulfiredoxin via an Nrf2-dependent pathway and hyperoxidation of peroxiredoxin III in the lungs of mice exposed to hyperoxia. Antioxid. Redox Signal 11 (2009) 937-948
3. Biteau B., Labarre J., and Toledano M.B. ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature 425 (2003) 980-984
4. Cao J., Schulte J., Knight A., Leslie N.R., Zagozdzon A., Bronson R., Manevich Y., Beeson C., and Neumann C.A. Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity. EMBO J. 28 (2009) 1505-1517
5. Carroll M., Ohno-Jones S., Tamura S., Buchdunger E., Zimmermann J., Lydon N.B., Gilliland D.G., and Druker B.J. CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins. Blood 90 (1997) 4947-4952
6. Chae H.Z., Kim H.J., Kang S.W., and Rhee S.G. Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Res. Clin. Pract. 45 (1999) 101-112
7. Cheng P.C., Brown B.K., Song W., and Pierce S.K. Translocation of the B cell antigen receptor into lipid rafts reveals a novel step in signaling. J. Immunol. 166 (2001) 3693-3701
8. Chiarugi P. Src redox regulation: there is more than meets the eye. Mol. Cells 26 (2008) 329-337
9. Chiarugi P., and Cirri P. Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction. Trends Biochem. Sci. 28 (2003) 509-514
10. Choi M.H., Lee I.K., Kim G.W., Kim B.U., Han Y.H., Yu D.Y., Park H.S., Kim K.Y., Lee J.S., Choi C., et al. Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 435 (2005) 347-353
11. Clempus R.E., and Griendling K.K. Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc. Res. 71 (2006) 216-225
12. D'Autréaux B., and Toledano M.B. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol. 8 (2007) 813-824
13. Jang H.H., Kim S.Y., Park S.K., Jeon H.S., Lee Y.M., Jung J.H., Lee S.Y., Chae H.B., Jung Y.J., Lee K.O., et al. Phosphorylation and concomitant structural changes in human 2-Cys peroxiredoxin isotype I differentially regulate its peroxidase and molecular chaperone functions. FEBS Lett. 580 (2006) 351-355
14. Kang S.W., Chae H.Z., Seo M.S., Kim K., Baines I.C., and Rhee S.G. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J. Biol. Chem. 273 (1998) 6297-6302
15. Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4 (2004) 181-189
16. Li Q., Harraz M.M., Zhou W., Zhang L.N., Ding W., Zhang Y., Eggleston T., Yeaman C., Banfi B., and Engelhardt J.F. Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes. Mol. Cell. Biol. 26 (2006) 140-154
17. Li Q., Zhang Y., Marden J.J., Banfi B., and Engelhardt J.F. Endosomal NADPH oxidase regulates c-Src activation following hypoxia/reoxygenation injury. Biochem. J. 411 (2008) 531-541
18. Lichti U., Anders J., and Yuspa S.H. Isolation and short-term culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice. Nat. Protoc. 3 (2008) 799-810
19. Martin P. Wound healing-aiming for perfect skin regeneration. Science 276 (1997) 75-81
20. Matsuno K., Yamada H., Iwata K., Jin D., Katsuyama M., Matsuki M., Takai S., Yamanishi K., Miyazaki M., Matsubara H., and Yabe-Nishimura C. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 112 (2005) 2677-2685
21. Miceli M.C., Moran M., Chung C.D., Patel V.P., Low T., and Zinnanti W. Co-stimulation and counter-stimulation: lipid raft clustering controls TCR signaling and functional outcomes. Semin. Immunol. 13 (2001) 115-128
22. Neumann C.A., Krause D.S., Carman C.V., Das S., Dubey D.P., Abraham J.L., Bronson R.T., Fujiwara Y., Orkin S.H., and Van Etten R.A. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 424 (2003) 561-565
23. Oakley F.D., Abbott D., Li Q., and Engelhardt J.F. Signaling components of redox active endosomes: the redoxosomes. Antioxid. Redox Signal 11 (2009) 1313-1333
24. Phalen T.J., Weirather K., Deming P.B., Anathy V., Howe A.K., van der Vliet A., Jönsson T.J., Poole L.B., and Heintz N.H. Oxidation state governs structural transitions in peroxiredoxin II that correlate with cell cycle arrest and recovery. J. Cell Biol. 175 (2006) 779-789
25. Plattner R., Kadlec L., DeMali K.A., Kazlauskas A., and Pendergast A.M. c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. Genes Dev. 13 (1999) 2400-2411
26. Prywes R., Livneh E., Ullrich A., and Schlessinger J. Mutations in the cytoplasmic domain of EGF receptor affect EGF binding and receptor internalization. EMBO J. 5 (1986) 2179-2190
27. Radeva G., and Sharom F.J. Isolation and characterization of lipid rafts with different properties from RBL-2H3 (rat basophilic leukaemia) cells. Biochem. J. 380 (2004) 219-230
28. Rhee S.G. Cell signaling. H2O2, a necessary evil for cell signaling. Science 312 (2006) 1882-1883
29. Rhee S.G., Kang S.W., Jeong W., Chang T.S., Yang K.S., and Woo H.A. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr. Opin. Cell Biol. 17 (2005) 183-189
30. Riento K., Frick M., Schafer I., and Nichols B.J. Endocytosis of flotillin-1 and flotillin-2 is regulated by Fyn kinase. J. Cell Sci. 122 (2009) 912-918
31. Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., Zha X.M., Polakiewicz R.D., and Comb M.J. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 23 (2005) 94-101
32. Sen C.K., and Roy S. Redox signals in wound healing. Biochim. Biophys. Acta 1780 (2008) 1348-1361
33. Singer A.J., and Clark R.A. Cutaneous wound healing. N. Engl. J. Med. 341 (1999) 738-746
34. Stone J.R., and Yang S. Hydrogen peroxide: a signaling messenger. Antioxid. Redox Signal. 8 (2006) 243-270
35. Sundaresan M., Yu Z.X., Ferrans V.J., Irani K., and Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270 (1995) 296-299
36. Tonks N.K. Redox redux: revisiting PTPs and the control of cell signaling. Cell 121 (2005) 667-670
37. Ushio-Fukai, M. (2006). Localizing NADPH Oxidase-derived ROS. Science's Stke, http://www.stke.org/cgi/content/full/2006/349/re8.
38. Valencia A., and Kochevar I.E. Nox1-based NADPH oxidase is the major source of UVA-induced reactive oxygen species in human keratinocytes. J. Invest. Dermatol. 128 (2008) 214-222
39. Wen S.T., and Van Etten R.A. The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes Dev. 11 (1997) 2456-2467
40. Woo H.A., Chae H.Z., Hwang S.C., Yang K.S., Kang S.W., Kim K., and Rhee S.G. Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science 300 (2003) 653-656
41. Woo H.A., Kang S.W., Kim H.K., Yang K.S., Chae H.Z., and Rhee S.G. Reversible oxidation of the active site cysteine of peroxiredoxins to cysteine sulfinic acid. Immunoblot detection with antibodies specific for the hyperoxidized cysteine-containing sequence. J. Biol. Chem. 278 (2003) 47361-47364
42. Wood Z.A., Poole L.B., and Karplus P.A. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 300 (2003) 650-653
43. Xu D., Rovira I.I., and Finkel T. Oxidants painting the cysteine chapel: redox regulation of PTPs. Dev. Cell 2 (2002) 251-252